Evidence map›Paper›PMID 36506384›Full record

ArticleHeliyon2022

A novel transfer-learning based physician-level general and subtype classifier for non-small cell lung cancer.

Bingzhang Qiao, Kawuli Jumai, Julaiti Ainiwaer, Madinyat Niyaz, Yingxin Zhang, Yuqing Ma, Liwei Zhang, Wesley Luh, Ilyar Sheyhidin

Abstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bingzhang QiaoDepartment of Thoracic Surgery, First Affiliated Hospital of Xinjiang Medical University, No.137 Liyu Shan Road, Urumqi, Xinjiang 830054, China.
Kawuli JumaiDepartment of Thoracic Surgery, First Affiliated Hospital of Xinjiang Medical University, No.137 Liyu Shan Road, Urumqi, Xinjiang 830054, China.
Julaiti AiniwaerDepartment of Thoracic Surgery, First Affiliated Hospital of Xinjiang Medical University, No.137 Liyu Shan Road, Urumqi, Xinjiang 830054, China.
Madinyat NiyazClinical Medicine Research Institute, First Affiliated Hospital of Xinjiang Medical University, No.137 Liyu Shan Road, Urumqi, Xinjiang 830054, China.
Yingxin ZhangJiaxing Qingge Medical Technologies Co. Ltd., Zhejiang, 314006, China.
Yuqing MaDepartment of Pathology, First Affiliated Hospital of Xinjiang Medical University, No.137 Liyu Shan Road, Urumqi, Xinjiang 830054, China.
Liwei ZhangDepartment of Thoracic Surgery, First Affiliated Hospital of Xinjiang Medical University, No.137 Liyu Shan Road, Urumqi, Xinjiang 830054, China.
Wesley LuhNew York University, New York, NY 10003.
Ilyar SheyhidinDepartment of Thoracic Surgery, First Affiliated Hospital of Xinjiang Medical University, No.137 Liyu Shan Road, Urumqi, Xinjiang 830054, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Confirming histological patterns of lung carcinoma is important for determining the prognosis and the next steps of treatment for a patient. Confirming the histologic patterns (subtype) of lung adenocarcinoma is important for determining the prognosis and treatment options for a patient. The task is challenging, and often requires the input of experienced pathologists, who by themselves lack interobserver concordance. A computer-aided diagnosis holds the potential to accelerate the time to diagnosis. As many adenocarcinoma tissue samples contain multiple histologic patterns, accurate computer-aided diagnosis requires annotations manually labeled by pathologists. We propose a method that merges weak supervised learning and Integrated Learning using Transfer Learning using two datasets: The Cancer Genome Atlas (TCGA), and the Clinical Proteomic Tumor Analysis Consortium (CPTAC) to reduce the need for manual annotation by a pathologist while maintaining accuracy. Whole-slide images (WSI) are first determined to be either adenocarcinoma or squamous cell carcinoma, then further identify the subtypes by generating weak classifiers for each subtype, then using integrated learning to create a strong classifier. Our model was evaluated with independent datasets from the CPTAC dataset and a dataset from a private hospital. It can achieve AUC values of 0.86, 0.91, 0.82, 0.77, 0.96, 0.98 in Acinar, LPA, Micropapillary, Papillary, Solid, and Normal, respectively.

Indexed as

Adenocarcinoma subtype classificationLung adenocarcinomaNSCLCSquamous cell carcinomaThe cancer genome atlasTransfer learningWeak supervised learning

Identifiers

PMID36506384
PMCPMC9727670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.